PharVision Advisers »

Kempharm shares owned by PharVision Advisers

Quarter-by-quarter ownership of Kempharm (ZVRA) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Kempharm

Tip: Access up to 7 years of quarterly data

All positions including Kempharm held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kempharm by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $635k 67k 9.51

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Kempharm

AIGH Capital Management
BlackRock
Woodline Partners
Vanguard Group
Caption Management
Adage Capital Partners GP
Nantahala Capital Management
FMR
Susquehanna International
State Street Corporation
Geode Capital Management
Legal & General Group
Millennium Management
683 Capital Management
Marshall Wace

View all funds holding Kempharm